Status:

COMPLETED

First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer

Lead Sponsor:

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Collaborating Sponsors:

Azienda Ospedaliero, Universitaria Ospedali Riuniti

Conditions:

Colorectal Cancer Stage II

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

Bevacizumab in combination with chemotherapy represents a standard of care for first-line treatment in patients with advanced colorectal cancer. Molecular predictive factors for bevacizumab efficacy h...

Detailed Description

The VEGF-driven tumour pathway has been demonstrated to represent a novel therapeutic target for an innovative class of antineoplastic agents. Among these antiangiogenetic-targeted treatment modalitie...

Eligibility Criteria

Inclusion

  • Written informed consent
  • No prior treatment for advanced disease (adjuvant therapy allowed)
  • age \< 75 years \< 18 years
  • Histologically/cytologically confirmed advanced, colorectal cancer
  • At least one lesion measurable with CT or MRI scan
  • Performance Status (ECOG) 0-1 at study entry)
  • Life expectancy of at least 6 months
  • Neutrophils count =/\> 1.5 x 109/L, platelets count =/\> 100 x 109/L, HGB =/\> 10 g/dL
  • total bilirubin \< 1.5 x UNL • SGOT and SGPT =/\< 2.5 x UNL (=/\< 5 x UNL in patients with liver metastases)
  • Creatinine \< 1.5 x UNL

Exclusion

  • CNS metastases
  • Severe cardiovascular disease
  • Uncontrolled infections
  • Radiotherapy within 4 weeks of study entry
  • Any experimental drug administered within 4 weeks of study entry
  • Known hypersensitivity to study drug
  • Known drugs or alcohol abuse
  • Pregnant or lactating women (serum Betahcg test)
  • Other tumours, except in situ melanoma or cervix cancer if radically removed
  • Incapability to sign informed consent

Key Trial Info

Start Date :

May 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2015

Estimated Enrollment :

85 Patients enrolled

Trial Details

Trial ID

NCT01853813

Start Date

May 1 2013

End Date

July 1 2015

Last Update

July 15 2015

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

A.O. Universitaria - Ospedali Riuniti

Ancona, Ancona, Italy, 60100

2

A.O. Ospedale G.Rummo

Benevento, Benevento, Italy, 82100

3

A.O. Treviglio-Caravaggio, P.le Ospedale n1

Treviglio, Bergamo, Italy, 24047

4

Istituto Ospedaliero Fondazione Poliambulanza

Brescia, Brescia, Italy, 25124